Another study found that the activity of natural killer (NK) cells was boosted by immune checkpoint blockade (targeting either PD-1 or T cell immunoreceptor with Ig and ITIM domains (TIGIT)) in combination with ATR inhibition and radiotherapy in a murine oral squamous cell carcinoma model (51). Here, ATR is linked to oral cavity squamous cell carcinoma.